• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global BRAF kinase inhibitors market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global braf kinase inhibitors market 2018 – 2022 ($ billion)
o 4.2 Product Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Product Segment 2018 – 2022 ($ billion)
o 4.3 Type Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Type Segment 2018 – 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product – Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Dabrafenib – Market size and forecast 2023-2028
o Exhibit 34: Chart on Dabrafenib – Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Dabrafenib – Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Dabrafenib – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Dabrafenib – Year-over-year growth 2023-2028 (%)
o 6.4 Sorafenib – Market size and forecast 2023-2028
o Exhibit 38: Chart on Sorafenib – Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Sorafenib – Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Sorafenib – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Sorafenib – Year-over-year growth 2023-2028 (%)
o 6.5 Vemurafenib – Market size and forecast 2023-2028
o Exhibit 42: Chart on Vemurafenib – Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Vemurafenib – Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Vemurafenib – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Vemurafenib – Year-over-year growth 2023-2028 (%)
o 6.6 Encorafenib – Market size and forecast 2023-2028
o Exhibit 46: Chart on Encorafenib – Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Data Table on Encorafenib – Market size and forecast 2023-2028 ($ billion)
o Exhibit 48: Chart on Encorafenib – Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Encorafenib – Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Product
o Exhibit 50: Market opportunity by Product ($ billion)
o Exhibit 51: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 52: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 53: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 54: Chart on Comparison by Distribution Channel
o Exhibit 55: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacies – Market size and forecast 2023-2028
o Exhibit 56: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o 7.4 Retail pharmacies – Market size and forecast 2023-2028
o Exhibit 60: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o 7.5 Online pharmacies – Market size and forecast 2023-2028
o Exhibit 64: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 68: Market opportunity by Distribution Channel ($ billion)
o Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 75: Chart on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 91: Chart on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 UK – Market size and forecast 2023-2028
o Exhibit 99: Chart on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.10 France – Market size and forecast 2023-2028
o Exhibit 103: Chart on France – Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on France – Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on France – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on France – Year-over-year growth 2023-2028 (%)
o 9.11 Japan – Market size and forecast 2023-2028
o Exhibit 107: Chart on Japan – Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on Japan – Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Asana BioSciences LLC
o Exhibit 119: Asana BioSciences LLC – Overview
o Exhibit 120: Asana BioSciences LLC – Product / Service
o Exhibit 121: Asana BioSciences LLC – Key offerings
o 12.4 Bayer AG
o Exhibit 122: Bayer AG – Overview
o Exhibit 123: Bayer AG – Business segments
o Exhibit 124: Bayer AG – Key news
o Exhibit 125: Bayer AG – Key offerings
o Exhibit 126: Bayer AG – Segment focus
o 12.5 BeiGene Ltd.
o Exhibit 127: BeiGene Ltd. – Overview
o Exhibit 128: BeiGene Ltd. – Business segments
o Exhibit 129: BeiGene Ltd. – Key offerings
o Exhibit 130: BeiGene Ltd. – Segment focus
o 12.6 Black Diamond Therapeutics Inc.
o Exhibit 131: Black Diamond Therapeutics Inc. – Overview
o Exhibit 132: Black Diamond Therapeutics Inc. – Product / Service
o Exhibit 133: Black Diamond Therapeutics Inc. – Key offerings
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 134: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 135: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 136: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 137: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 138: F. Hoffmann La Roche Ltd. – Segment focus
o 12.8 Fore Biotherapeutics Inc.
o Exhibit 139: Fore Biotherapeutics Inc. – Overview
o Exhibit 140: Fore Biotherapeutics Inc. – Product / Service
o Exhibit 141: Fore Biotherapeutics Inc. – Key offerings
o 12.9 Jazz Pharmaceuticals Plc
o Exhibit 142: Jazz Pharmaceuticals Plc – Overview
o Exhibit 143: Jazz Pharmaceuticals Plc – Product / Service
o Exhibit 144: Jazz Pharmaceuticals Plc – Key news
o Exhibit 145: Jazz Pharmaceuticals Plc – Key offerings
o 12.10 Kinnate Biopharma
o Exhibit 146: Kinnate Biopharma – Overview
o Exhibit 147: Kinnate Biopharma – Product / Service
o Exhibit 148: Kinnate Biopharma – Key offerings
o 12.11 Nerviano Medical Sciences S.r.l
o Exhibit 149: Nerviano Medical Sciences S.r.l – Overview
o Exhibit 150: Nerviano Medical Sciences S.r.l – Product / Service
o Exhibit 151: Nerviano Medical Sciences S.r.l – Key offerings
o 12.12 Novartis AG
o Exhibit 152: Novartis AG – Overview
o Exhibit 153: Novartis AG – Business segments
o Exhibit 154: Novartis AG – Key offerings
o Exhibit 155: Novartis AG – Segment focus
o 12.13 Ono Pharmaceutical Co. Ltd.
o Exhibit 156: Ono Pharmaceutical Co. Ltd. – Overview
o Exhibit 157: Ono Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 158: Ono Pharmaceutical Co. Ltd. – Key offerings
o 12.14 Pfizer Inc.
o Exhibit 159: Pfizer Inc. – Overview
o Exhibit 160: Pfizer Inc. – Product / Service
o Exhibit 161: Pfizer Inc. – Key news
o Exhibit 162: Pfizer Inc. – Key offerings
o 12.15 Pierre Fabre SA
o Exhibit 163: Pierre Fabre SA – Overview
o Exhibit 164: Pierre Fabre SA – Business segments
o Exhibit 165: Pierre Fabre SA – Key offerings
o Exhibit 166: Pierre Fabre SA – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 167: Inclusions checklist
o Exhibit 168: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 169: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 170: Research methodology
o Exhibit 171: Validation techniques employed for market sizing
o Exhibit 172: Information sources
o 13.5 List of abbreviations
o Exhibit 173: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global braf kinase inhibitors market 2018 – 2022 ($ billion)
Exhibits19: Historic Market Size – Product Segment 2018 – 2022 ($ billion)
Exhibits20: Historic Market Size – Type Segment 2018 – 2022 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Product – Market share 2023-2028 (%)
Exhibits31: Data Table on Product – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Dabrafenib – Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Dabrafenib – Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Dabrafenib – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Dabrafenib – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Sorafenib – Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Sorafenib – Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Sorafenib – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Sorafenib – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Vemurafenib – Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Vemurafenib – Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Vemurafenib – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Vemurafenib – Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Encorafenib – Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Encorafenib – Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Encorafenib – Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Encorafenib – Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Product ($ billion)
Exhibits51: Data Table on Market opportunity by Product ($ billion)
Exhibits52: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits53: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Distribution Channel
Exhibits55: Data Table on Comparison by Distribution Channel
Exhibits56: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Distribution Channel ($ billion)
Exhibits69: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US – Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on US – Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on France – Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on France – Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on France – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on France – Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Japan – Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on Japan – Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Asana BioSciences LLC – Overview
Exhibits120: Asana BioSciences LLC – Product / Service
Exhibits121: Asana BioSciences LLC – Key offerings
Exhibits122: Bayer AG – Overview
Exhibits123: Bayer AG – Business segments
Exhibits124: Bayer AG – Key news
Exhibits125: Bayer AG – Key offerings
Exhibits126: Bayer AG – Segment focus
Exhibits127: BeiGene Ltd. – Overview
Exhibits128: BeiGene Ltd. – Business segments
Exhibits129: BeiGene Ltd. – Key offerings
Exhibits130: BeiGene Ltd. – Segment focus
Exhibits131: Black Diamond Therapeutics Inc. – Overview
Exhibits132: Black Diamond Therapeutics Inc. – Product / Service
Exhibits133: Black Diamond Therapeutics Inc. – Key offerings
Exhibits134: F. Hoffmann La Roche Ltd. – Overview
Exhibits135: F. Hoffmann La Roche Ltd. – Business segments
Exhibits136: F. Hoffmann La Roche Ltd. – Key news
Exhibits137: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits139: Fore Biotherapeutics Inc. – Overview
Exhibits140: Fore Biotherapeutics Inc. – Product / Service
Exhibits141: Fore Biotherapeutics Inc. – Key offerings
Exhibits142: Jazz Pharmaceuticals Plc – Overview
Exhibits143: Jazz Pharmaceuticals Plc – Product / Service
Exhibits144: Jazz Pharmaceuticals Plc – Key news
Exhibits145: Jazz Pharmaceuticals Plc – Key offerings
Exhibits146: Kinnate Biopharma – Overview
Exhibits147: Kinnate Biopharma – Product / Service
Exhibits148: Kinnate Biopharma – Key offerings
Exhibits149: Nerviano Medical Sciences S.r.l – Overview
Exhibits150: Nerviano Medical Sciences S.r.l – Product / Service
Exhibits151: Nerviano Medical Sciences S.r.l – Key offerings
Exhibits152: Novartis AG – Overview
Exhibits153: Novartis AG – Business segments
Exhibits154: Novartis AG – Key offerings
Exhibits155: Novartis AG – Segment focus
Exhibits156: Ono Pharmaceutical Co. Ltd. – Overview
Exhibits157: Ono Pharmaceutical Co. Ltd. – Product / Service
Exhibits158: Ono Pharmaceutical Co. Ltd. – Key offerings
Exhibits159: Pfizer Inc. – Overview
Exhibits160: Pfizer Inc. – Product / Service
Exhibits161: Pfizer Inc. – Key news
Exhibits162: Pfizer Inc. – Key offerings
Exhibits163: Pierre Fabre SA – Overview
Exhibits164: Pierre Fabre SA – Business segments
Exhibits165: Pierre Fabre SA – Key offerings
Exhibits166: Pierre Fabre SA – Segment focus
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations